Editas Medicine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
EDIT Key Statistics
Stock Snapshot
As of today, Editas Medicine(EDIT) shares are valued at $1.79. The company's market cap stands at 176.2M, with a P/E ratio of -0.76.
As of 2026-02-19, Editas Medicine(EDIT) stock has fluctuated between $1.67 and $1.82. The current price stands at $1.79, placing the stock +7.2% above today's low and -1.4% off the high.
The Editas Medicine(EDIT)'s current trading volume is 1.49M, compared to an average daily volume of 1.34M.
In the last year, Editas Medicine(EDIT) shares hit a 52-week high of $4.54 and a 52-week low of $0.91.
In the last year, Editas Medicine(EDIT) shares hit a 52-week high of $4.54 and a 52-week low of $0.91.
Analyst ratings
43%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.